UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
79 hedge funds and large institutions have $157M invested in Unity Biotechnology in 2019 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 34 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
+16
Holders Change %
+25.4%
% of All Funds
1.56%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.04%
New
21
Increased
34
Reduced
10
Closed
5
Calls
$2K
Puts
$4K
Net Calls
-$2K
Net Calls Change
-$2K
Top Buyers
| 1 |
1
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$2.43M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$35M |
| 3 |
3
Millennium Management
New York
|
$2.88M |
| 4 |
4
BlackRock
New York
|
$15.9M |
| 5 |
5
Morgan Stanley
New York
|
$1.59M |
